Idinvest et al. inject $15m into Biomodex

The series-A was led by Idinvest Partners and InnovAllianz. The latter is the corporate venturing arm of insurance company Allianz.

They were joined by previous backers LBO France and Inserm  Transfert Initiative; the former invested in the business in 2016 via its Sisa venture fund.

Biomodex has now raised a total of $18.5m.

The latest financing will be used to develop new products in the interventional cardiology space, and enable the opening of a new manufacturing facility outside Boston.

Company
Dual-headquartered in Paris and Boston, Biomodex develops life-like 3D-printed replicas of patient anatomy directly from their medical images, with the aim of delivering a planning and practicing experience for interventional procedures.

People
Idinvest Partners – Luc Maruenda (partner).
LBO France – Valery Huot (partner).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• Healthcare
• France
• France
• United States
• IDInvest Partners (AGF Private Equity)
• LBO France
• Venture